If you are curious about Staar Implantable Collamer Lenses (ICL) and you’d like to learn how you can provide shared care for the patients

Scientists have discovered compelling evidence for the cytoprotective and proregenerative effects of a neuropeptide in promoting corneal healing after eye injury.

A Phase 3 trial for an ophthalmic solution for treating patients with night vision disturbances is expected to begin soon.

World Optometry Week, from 17–23 March, will be themed ‘Advancing optometry’s commitment to global eye care’.